Payment overview · 2025
General Payments
$14.11
1 reported records · 1 companies
Healthcare provider profile · identity verified
Susan E Fanta, MD
Allopathic & Osteopathic Physicians|Internal Medicine · YANKTON, SD · NPI 1326049313
Verified facts
What the public records show
CMS Open Payments records show Susan E Fanta, MD received $14.11 in general payments during 2025 across 1 reported records.
Dexcom, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $14.11 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $14.11 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $14.11 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 920 | 189 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 885 | 219 |
| Amlodipine Besylate | Amlodipine Besylate | 641 | 146 |
| Chlorthalidone | Chlorthalidone | 552 | 138 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 527 | 135 |
| Omeprazole | Omeprazole | 527 | 123 |
| Eliquis | Apixaban | 526 | 80 |
| Pravastatin Sodium | Pravastatin Sodium | 515 | 116 |
| Atorvastatin Calcium | Atorvastatin Calcium | 506 | 103 |
| Metoprolol Succinate | Metoprolol Succinate | 489 | 122 |
| Lisinopril | Lisinopril | 472 | 125 |
| Irbesartan | Irbesartan | 438 | 94 |
| Potassium Chloride | Potassium Chloride | 308 | 73 |
| Gabapentin | Gabapentin | 287 | 64 |
| Pantoprazole Sodium | Pantoprazole Sodium | 281 | 67 |
| Spironolactone | Spironolactone | 273 | 63 |
| Mirtazapine | Mirtazapine | 271 | 50 |
| Tamsulosin Hcl | Tamsulosin Hcl | 254 | 54 |
| Montelukast Sodium | Montelukast Sodium | 251 | 60 |
| Escitalopram Oxalate | Escitalopram Oxalate | 248 | 51 |
| Tramadol Hcl | Tramadol Hcl | 244 | 56 |
| Furosemide | Furosemide | 225 | 61 |
| Duloxetine Hcl | Duloxetine Hcl | 213 | 57 |
| Metoprolol Tartrate | Metoprolol Tartrate | 203 | 52 |
| Metformin Hcl | Metformin Hcl | 201 | 47 |
| Carvedilol | Carvedilol | 196 | 45 |
| Alendronate Sodium | Alendronate Sodium | 189 | 46 |
| Trazodone Hcl | Trazodone Hcl | 175 | 44 |
| Losartan Potassium | Losartan Potassium | 172 | 45 |
| Prednisone | Prednisone | 160 | 125 |
| Sertraline Hcl | Sertraline Hcl | 159 | 36 |
| Oxycodone Hcl | Oxycodone Hcl | 144 | 36 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 142 | 29 |
| Famotidine | Famotidine | 130 | 38 |
| Warfarin Sodium | Warfarin Sodium | 122 | 27 |
| Fluoxetine Hcl | Fluoxetine Hcl | 107 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 105 | 24 |
| Finasteride | Finasteride | 102 | 20 |
| Fluticasone Propionate | Fluticasone Propionate | 102 | 36 |
| Mounjaro | Tirzepatide | 100 | 20 |
| Simvastatin | Simvastatin | 98 | 26 |
| Valsartan | Valsartan | 94 | 23 |
| Zolpidem Tartrate | Zolpidem Tartrate | 93 | 28 |
| Donepezil Hcl | Donepezil Hcl | 92 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 87 | 22 |
| Lorazepam | Lorazepam | 81 | 20 |
| Metformin Hcl Er | Metformin Hcl | 77 | 29 |
| Memantine Hcl | Memantine Hcl | 75 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 74 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 70 | 46 |
| Estradiol | Estradiol | 70 | 34 |
| Ondansetron Odt | Ondansetron | 70 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 69 | 17 |
| Trulicity | Dulaglutide | 69 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 68 | 16 |
| Buspirone Hcl | Buspirone Hcl | 67 | 16 |
| Levetiracetam | Levetiracetam | 64 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 63 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 62 | 11 |
| Nortriptyline Hcl | Nortriptyline Hcl | 60 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 59 | 18 |
| Jardiance | Empagliflozin | 58 | 12 |
| Meloxicam | Meloxicam | 57 | 20 |
| Torsemide | Torsemide | 57 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 57 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 56 | 50 |
| Breo Ellipta | Fluticasone/Vilanterol | 56 | 12 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 55 | 23 |
| Allopurinol | Allopurinol | 53 | 15 |
| Latanoprost | Latanoprost | 52 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 48 | 19 |
| Ozempic | Semaglutide | 47 | suppressed |
| Synthroid | Levothyroxine Sodium | 47 | 18 |
| Xarelto | Rivaroxaban | 47 | suppressed |
| Clonazepam | Clonazepam | 46 | 11 |
| Ezetimibe | Ezetimibe | 43 | 13 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 43 | 39 |
| Tresiba Flextouch U-100 | Insulin Degludec | 41 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 40 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 39 | suppressed |
| Cefdinir | Cefdinir | 38 | 34 |
| Farxiga | Dapagliflozin Propanediol | 38 | 12 |
| Gemtesa | Vibegron | 38 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 38 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 38 | 16 |
| Bupropion Hcl Sr | Bupropion Hcl | 37 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 36 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 33 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 33 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 33 | suppressed |
| Bupropion Xl | Bupropion Hcl | 32 | 11 |
| Ibandronate Sodium | Ibandronate Sodium | 32 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 32 | 22 |
| Azithromycin | Azithromycin | 31 | 30 |
| Baclofen | Baclofen | 31 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 31 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 31 | suppressed |
| Movantik | Naloxegol Oxalate | 30 | suppressed |
| Alprazolam | Alprazolam | 29 | suppressed |
| Glimepiride | Glimepiride | 29 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 29 | suppressed |
| Cephalexin | Cephalexin | 28 | 23 |
| Dilt-Xr | Diltiazem Hcl | 28 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 28 | suppressed |
| Myrbetriq | Mirabegron | 28 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Anastrozole | Anastrozole | 27 | suppressed |
| Nystatin | Nystatin | 27 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 26 | suppressed |
| Lactulose | Lactulose | 25 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 25 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 24 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 24 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 24 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 24 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Atenolol | Atenolol | 23 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 23 | suppressed |
| Levofloxacin | Levofloxacin | 23 | 19 |
| Diltiazem 24hr Er | Diltiazem Hcl | 22 | suppressed |
| Glipizide Er | Glipizide | 22 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 16 |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Timolol Maleate | Timolol Maleate | 21 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 21 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 20 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 19 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 19 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 19 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Loperamide | Loperamide Hcl | 19 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 19 | suppressed |
| Topiramate | Topiramate | 19 | suppressed |
| Acyclovir | Acyclovir | 18 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 18 | 18 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Amoxicillin | Amoxicillin | 17 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 16 | 13 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 16 | suppressed |
| Klor-Con M20 | Potassium Chloride | 16 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Nitroglycerin | Nitroglycerin | 16 | 15 |
| Rybelsus | Semaglutide | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 15 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 15 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 15 | suppressed |
| Pregabalin | Pregabalin | 15 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 15 | suppressed |
| Repatha Sureclick | Evolocumab | 15 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | 12 |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 14 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 14 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Pyridostigmine Bromide Er | Pyridostigmine Bromide | 13 | suppressed |
| Rhopressa | Netarsudil Mesylate | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Xifaxan | Rifaximin | 13 | suppressed |
| Aripiprazole | Aripiprazole | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Dofetilide | Dofetilide | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 12 | suppressed |
| Ursodiol | Ursodiol | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Clozapine | Clozapine | 11 | suppressed |
| Methocarbamol | Methocarbamol | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | 11 |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $14.11 · 1 records | Dexcom, Inc. | Dexcom G6 Transmitter | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error